Reference : Evaluation of detemir in diabetic cats managed with a protocol for intensive blood gl...
Scientific journals : Article
Life sciences : Multidisciplinary, general & others
http://hdl.handle.net/10993/26995
Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control
English
Roomp, Kirsten mailto [University of Luxembourg > Luxembourg Centre for Systems Biomedicine (LCSB) > >]
Rand, Jacquie [The University of Queensland > Centre for Companion Animal Health, School of Veterinary Science]
2012
Journal of Feline Medicine and Surgery
W.B. Saunders
14
8
566-572
Yes
1098-612X
London
United Kingdom
[en] The aim of this study was to report outcomes using detemir and a protocol aimed at intensive blood glucose control with home monitoring in diabetic cats, and to compare the results with a previous study using the same protocol with glargine. Eighteen cats diagnosed with diabetes and previously treated with other insulins were included in the study. Data was provided by owners who joined the online German Diabetes-Katzen Forum. The overall remission rate was 67%. For cats that began the protocol before or after 6 months of diagnosis, remission rates were 81% and 42%, respectively (P = 0.14). No significant differences were identified between the outcomes for the glargine and detemir studies, with the exception of three possibly interrelated factors: a slightly older median age of the detemir cohort at diabetes diagnosis, a higher rate of chronic renal disease in the detemir cohort and lower maximal dose for insulin detemir.
Luxembourg Centre for Systems Biomedicine (LCSB): Bioinformatics Core (R. Schneider Group)
http://hdl.handle.net/10993/26995
10.1177/1098612X12446211

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Limited access
Evaluation of detemir in diabetic cats managed with a protocol for intensive blood glucose control.pdfPublisher postprint732.91 kBRequest a copy

Bookmark and Share SFX Query

All documents in ORBilu are protected by a user license.